| Financial Year |
March 31 2023 |
| Monetary Funds |
817,881,430.80 |
| Held-for-trading Financial Assets |
1,743,620.00 |
| Notes Receivable |
106,473,783.15 |
| Accounts Receivable |
1,350,728,770.07 |
| Advances to Suppliers |
188,000,668.83 |
| Other Receivables |
79,861,530.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,189,215,852.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
33,354,723.12 |
| Other Current Assets |
76,036,081.35 |
| Total Current Assets |
5,154,417,831.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,647,561,860.55 |
| Under-construction Projects |
84,706,228.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
144,577,410.68 |
| R&D expenses |
-- |
| Goodwill |
531,589,804.23 |
| Long-Term Deferred and Prepaid Expenses |
8,800,987.75 |
| Deferred Income Tax Assets |
45,520,974.34 |
| Other Non-Current Assets |
102,093,228.90 |
| Sub-Total of Non-Current Assets |
2,638,377,246.72 |
| Total Assets |
7,792,795,077.74 |
| Short-Term Loans |
1,403,451,066.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
428,432,503.44 |
| Accounts Payable |
472,431,445.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
25,703,434.90 |
| Taxes Payable |
10,246,167.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
71,019,649.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
187,393,676.60 |
| Other Current Liabilities |
48,770,222.57 |
| Sub-Total of Current Liabilities |
3,148,730,560.27 |
| Long-term Loans |
864,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
82,599,198.62 |
| Special Payable |
-- |
| Estimatied Liabilities |
18,183,167.95 |
| Deferred Income Tax Liabilities |
5,548,133.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,056,396,101.71 |
| Total Liabilities |
4,205,126,661.98 |
| Paid-In Capital(Or Share Stock) |
1,032,781,167.00 |
| Capital Surplus |
2,916,872,949.71 |
| Surplus Reserve |
54,501,181.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-413,913,492.28 |
| Minority Stockholder's Interest |
2,762,017.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,584,906,398.54 |
| Owner's Equity（Stockholder's Equity） |
3,587,668,415.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,792,795,077.74 |
